Updated COVID Early Treatment Protocol and Practice Updates
Covid is back, and unfortunately we are still seeing severe cases in patients who have not received early treatment, regardless of their vaccination status. In the last 5 weeks, 68% of the patients who have received monoclonal antibodies at BreatheMD were vaccinated. Early treatment is the most effective way to fight COVID, and Dr. Bowden has kept over 2300 patients out of the hospital with this approach.
The Omicron variant has behaved differently than Delta. Cases are in general less severe and less likely to be associated with loss of smell and taste. Sore throat is more common. None-the-less, we have still seen very sick patients.
The most recent COVID strain, BA.2.12.1 - a sub variant of Omicron - is spreading quickly but responds well to early treatment. BreatheMD currently has an ample supply of monoclonal antibodies. Bebtelovimab by Eli Lilly is the most recent version with EUA approval, and people are noticing a fast response. If you have received Bebtolvimab, please complete this brief survey to let us know how it worked.
During the height of Omicron, BreatheMD had no access to monoclonal antibodies, and we confirmed that early treatment protocols designed by FLCCC work well. For patients with acute illness from COVID, Dr. Bowden prescribes hydroxychloroquine and ivermectin the first week of illness, then adds oral steroids, azithromycin and steroid breathing treatments the second week if necessary. In addition, she recommends Pepcid 20mg twice a day, Melatonin 10mg before bed, Vitamin C 2000mg twice a day, Quercetin 250mg a day, Zinc 100mg a day, Vitamin D 5000IU a day (add magnesium and K2 to improve absorption of Vitamin D). Frequent irrigation of the nose and throat with saline + betadine as described on the FLCCC website has been shown to decrease viral load. Patients should monitor their oxygen level with a pulse oximeter and purchase a nebulizer machine to have on hand in case they need breathing treatments.
For patients who have come in the second or third week of illness in respiratory distress, she administers IV solumedrol, azithromycin, Pepcid, zinc, high-dose Vitamin C, and glutathione, in addition to budesonide nebulizer treatments. Using this approach, Dr. Bowden has kept over two dozen patients out of the hospital who have walked in to the clinic with oxygen levels in the 70s-80s.
In other news, BreatheMD is growing. We will have a new full-time ENT joining the practice on August 15th and are bringing on a Patient Advocate to help families navigate the hospital experience. Dr Bowden is also starting a micro-hospital with Dr. Joe Varon where patients can get treated for acute respiratory illnesses without fear.
Dr Bowden is seeing a large number of patients with vaccine injuries and long-haul COVID. Most patients are responding well to ivermectin but other medications are available if not.
Finally, to help those who are burdened by mandatory testing, BreatheMD is discounting our PCR saliva test by 20%. Use code “MANDATE” when scheduling to receive the discount.
Thank you for all your support. We are facing a type of adversary never seen in history, and we encourage everyone to speak up and fight back.